Noriyuki Kasagi

This inventor holds 9 USPTO granted patents and 11 published patent applications, plus 1 CIPO patent and 7 EPO patents. Top assignee: Fujifilm Corporation. Active years: 2013-2022.

USPTO Granted Patents = 9 (Patent Applications = 11)

% Patents Active = 88.9

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 7 (Patent Applications = 11)

Average Co-Inventor Count = 2.7

ph-index = 2

Forward Citations = 10(Granted Patents)

Location History:

Kanagawa, JP (2013 - 2022)
Ashigarakami-gun, JP (2014 - 2022)

Company Filing History:

9 out of 16,893

Fujifilm Corporation

patents

Years Active: 2013-2022

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11446247 - Liposome composition and pharmaceutical composition (2022-09-20),

2. 11413244 - Liposome composition and pharmaceutical composition (2022-08-16),

3. 11255849 - Kit for quantitatively determining substance to be measured in biological sample (2022-02-22),

4. 10883986 - Kit for quantitatively determining bile acid in biological sample, and method for quantitatively determining bile acid in biological sample (2021-01-05),

5. 10816469 - Kit for quantitatively determining substance to be measured in biological sample and method for quantitatively determining substance to be measured in biological sample (2020-10-27),

6. 10161935 - Test substance measurement kit and test substance measurement method (2018-12-25),

7. 9296814 - Antibody against human TSH and canine TSH (2016-03-29),

8. 8912010 - Thyroxine immunoassay using fluorescent particles (2014-12-16),

9. 8524864 - Method for producing conjugate of thyroxine and albumin (2013-09-03),

Title: Noriyuki Kasagi: Innovator in Liposome Technology

Introduction

Noriyuki Kasagi is a prominent inventor based in Ashigarakami-gun, Japan. He has made significant contributions to the field of pharmaceutical compositions, particularly in the development of liposome technology. With a total of 9 patents to his name, his work has the potential to impact drug delivery systems significantly.

Latest Patents

Kasagi's latest patents focus on liposome compositions and pharmaceutical compositions that exhibit a high area under the curve (AUC). These innovations include a liposome composition that incorporates a hydrophilic polymer-modified diacylphosphatidylethanolamine, dihydrosphingomyelin, and cholesterols as components of the liposome membrane. The liposome composition is designed to encapsulate a drug, with an inner water phase containing ammonium sulfate. Notably, the molar ratio of sulfate ions in the inner water phase to the drug in the entire water phase is 0.36 or more. This advancement aims to enhance the efficacy of drug delivery systems.

Career Highlights

Noriyuki Kasagi is currently associated with Fujifilm Corporation, where he continues to innovate in the field of pharmaceutical technology. His work has garnered attention for its potential applications in improving drug delivery mechanisms.

Collaborations

Kasagi has collaborated with notable colleagues, including Hiroyuki Chiku and Naoki Yamada. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Noriyuki Kasagi's contributions to liposome technology and pharmaceutical compositions highlight his role as a key innovator in the field. His ongoing work promises to enhance drug delivery systems, making significant strides in pharmaceutical science.